腹腔镜与开腹扩大根治性左胰腺切除术治疗胰腺导管腺癌:国际倾向性评分匹配研究
该国际多中心倾向性评分匹配研究比较了腹腔镜与开腹扩大根治性左胰腺切除术治疗胰腺导管腺癌的效果。匹配后每组44例,腹腔镜组转开腹率35%,R0切除率与开腹组相当(67% vs 48%,P=0.063),但淋巴结检出数较少(中位11 vs 19,P=0.023),延迟胃排空更少(0% vs 16%,P=0.006),住院时间更短(中位9 vs 13天,P=0.005),总生存无差异(中位19 vs 20个月,P=0.571)。
要点
- 腹腔镜扩大根治性左胰腺切除术在选定患者中安全可行,总生存与开腹相当。
- 腹腔镜组转开腹率较高(35%),淋巴结检出数低于开腹组。
- 腹腔镜组延迟胃排空更少、住院时间更短,但R0切除率无统计学差异。
核心结论
- 对于需要扩大根治性左胰腺切除术的胰腺导管腺癌选定患者,腹腔镜 approach 可安全使用,因为发病率、死亡率和总生存与开腹组似乎相当。
- 腹腔镜扩大根治性左胰腺切除术与高转开腹率和减少的淋巴结检出数相关,但也与更少的延迟胃排空和更短的住院时间相关。
研究设计与样本
- 国际多中心倾向性评分匹配研究,纳入2007-2015年接受腹腔镜或开腹扩大根治性左胰腺切除术的胰腺导管腺癌患者。
- 共320例患者来自12个国家34个中心(65例腹腔镜 vs 255例开腹),倾向性评分匹配后44例腹腔镜与44例开腹配对。
- 采用ISGPS定义扩大切除,主要结局为总生存、切缘阴性率(R0)和淋巴结检出数。
主要发现
- 匹配队列中腹腔镜组转开腹率为35%。
- 腹腔镜组R0切除率与开腹组相当(67% vs 48%;P=0.063)。
- 腹腔镜组淋巴结检出数低于开腹组(中位11 vs 19,P=0.023)。
- 腹腔镜组延迟胃排空更少(0% vs 16%,P=0.006),住院时间更短(中位9 vs 13天,P=0.005)。
- 两组在额外器官切除、血管切除(脾血管除外)、Clavien-Dindo≥III级并发症或90天死亡率(2% vs 2%,P=0.973)方面结局相当,中位总生存无差异(19 vs 20个月,P=0.571)。
临床怎么用
- 在选定需扩大根治性左胰腺切除术的胰腺导管腺癌患者中,可考虑腹腔镜 approach,但需告知转开腹可能性较高。
- 腹腔镜手术可能减少延迟胃排空并缩短住院时间,但需注意淋巴结检出数可能较少。
局限性
- 匹配后样本量较小(每组44例),可能影响统计效能。
- 为回顾性多中心研究,存在选择偏倚可能。
- 腹腔镜组转开腹率较高(35%),可能影响结果解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A radical left pancreatectomy in patients with pancreatic ductal adenocarcinoma (PDAC) may require extended, multivisceral resections. The role of a laparoscopic approach in extended radical left pancreatectomy (ERLP) is unclear since comparative studies are lacking. The aim of this study was to compare outcomes after laparoscopic vs open ERLP in patients with PDAC. METHODS: An international multicenter propensity-score matched study including patients who underwent either laparoscopic or open ERLP (L-ERLP; O-ERLP) for PDAC was performed (2007-2015). The ISGPS definition for extended resection was used. Primary outcomes were overall survival, margin negative rate (R0), and lymph node retrieval. RESULTS: Between 2007 and 2015, 320 patients underwent ERLP in 34 centers from 12 countries (65 L-ERLP vs. 255 O-ERLP). After propensity-score matching, 44 L-ERLP could be matched to 44 O-ERLP. In the matched cohort, the conversion rate in L-ERLP group was 35%. The L-ERLP R0 resection rate (matched cohort) was comparable to O-ERLP (67% vs 48%; P = 0.063) but the lymph node yield was lower for L-ERLP than O-ERLP (median 11 vs 19, P = 0.023). L-ERLP was associated with less delayed gastric emptying (0% vs 16%, P = 0.006) and shorter hospital stay (median 9 vs 13 days, P = 0.005), as compared to O-ERLP. Outcomes were comparable for additional organ resections, vascular resections (besides splenic vessels), Clavien-Dindo grade ≥ III complications, or 90-day mortality (2% vs 2%, P = 0.973). The median overall survival was comparable between both groups (19 vs 20 months, P = 0.571). Conversion did not worsen outcomes in L-ERLP. CONCLUSION: The laparoscopic approach may be used safely in selected patients requiring ERLP for PDAC, since morbidity, mortality, and overall survival seem comparable, as compared to O-ERLP. L-ERLP is associated with a high conversion rate and reduced lymph node yield but also with less delayed gastric emptying and a shorter hospital stay, as compared to O-ERLP.
引用
- Balduzzi A, van Hilst J, Korrel M, et al. Laparoscopic versus open extended radical left pancreatectomy for pancreatic ductal adenocarcinoma: an international propensity-score matched study. Surg Endosc. 2021. PMID: 33398565. doi:10.1007/s00464-020-08206-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。